In a recent turn of events, Apple has been compelled to disable the blood oxygen sensor feature on specific models of its Apple Watch. This decision, affecting the Apple Watch Ultra 2 and Apple Watch Series 9 sold in the United States, is a result of an ongoing legal dispute with medical device manufacturer Masimo. The accusations revolve around Apple allegedly infringing on Masimo’s blood oxygen technology patents. This article discusses why Apple is removing the blood oxygen sensor from new Apple Watch models sold in the US and explores the implications for the future of health monitoring in Apple Watches.
Table of Contents
Legal Battle Unfolds
The clash between Apple and Masimo has taken a legal turn, leading to Apple removing blood oxygen sensor from certain Apple Watch models. Let’s delve into the details:
ITC Ruling and Temporary Lift
The situation escalated in December when the U.S. International Trade Commission (USITC) ruled in favor of Masimo, demanding that Apple stop selling Watches with the blood oxygen sensor in the United States. However, a federal circuit court temporarily lifted the ban as Apple pursued an appeal against the ITC ruling.
U.S. Court of Appeals Decision
Despite the temporary relief, a recent decision from a U.S. court of appeals reinstated the ban, presenting Apple with a challenging dilemma regarding removing blood oxgen sensor.
Apple’s Tough Decision
Options Considered
Faced with limited choices, Apple had to make a challenging decision. The options were either to halt the sale of affected models in the United States during the lengthy appeal process or disable the blood oxygen sensor and continue selling them. Apple chose the latter, resulting in the sensor hardware being present but non-functional.
User Experience
For users who purchased affected models before this decision, their blood oxygen sensors and apps will continue to operate as usual. However, for new buyers, the Blood Oxygen app will display an alert stating that the feature is not available.
Global Impact and Future Implications
International Reach
The ITC ruling’s scope is limited to the United States, allowing the blood oxygen sensor to remain unaffected in watches sold in other countries worldwide. Users outside the US can still enjoy the full functionality of the Apple Watch’s blood oxygen sensor.
Questions About Apple’s Health Focus
The removal of the blood oxygen sensor raises questions about the future of health-related features in Apple’s smartwatches. With a growing emphasis on health and fitness tracking, this setback could potentially impact Apple’s standing in the wearables market.
Stakeholder Responses
Masimo’s Perspective
Masimo CEO Joe Kiani emphasizes the importance of respecting intellectual rights, stating that even the largest companies must acknowledge the consequences of infringing on patents.
Apple’s Strong Disagreement
In response to the recent court ruling, Apple expressed strong disagreement, highlighting the company’s commitment to challenging the decision.
Uncertain Future
As the legal battle continues, the fate of the blood oxygen sensor in Apple Watches remains uncertain. Apple’s next steps and potential resolutions to the patent dispute will likely shape the future of health monitoring features in their wearable devices. Will Apple find a way to reintegrate the blood oxygen sensor or come up with alternative health tracking technologies? Only time will tell.
| Read More From Apple
- So Much For $3500, No Wifi 6E Support In Apple Vision Pro
- Apple Vision Pro: All the AR/VR Games Coming to Apple Vision Pro at Launch
- Siri 2.0: Apple is Planning to Drop a New Gen AI Version of Siri at WWDC 2024
- Apple Sell Signal: Can the Tech Giant Recover in 2024?
- Apple Enters the Multimodal AI Race with Open-Source Ferret LLM
- Apple Bites Into AI: Siri Is Going To Replaced Soon With This New Apple’s LLM
- Inside Apple’s Covert AI Creation: Apple GPT
- Here is everything you missed in Apple’s WWDC 2023 including WatchOS 10!
- Is Apple lagging behind in the Tech race against AI Chatbots?
| Recent From Us
- Forget Towers: Verizon and AST SpaceMobile Are Launching Cellular Service From Space
- This $1,600 Graphics Card Can Now Run $30,000 AI Models, Thanks to Huawei
- The Global AI Safety Train Leaves the Station: Is the U.S. Already Too Late?
- The AI Breakthrough That Solves Sparse Data: Meet the Interpolating Neural Network
- The AI Advantage: Why Defenders Must Adopt Claude to Secure Digital Infrastructure
